Diffuse optical tomography (DOT) to use for breast cancer screening. Image by Clemson University.


October 7, 2009 - Mathematical solutions to enhance the image quality of diffuse optical tomography (DOT) to use for breast cancer screening is in development at Clemson University in collaboration with researchers at the University of Bremen, Germany.

The challenge with DOT is to create high-resolution images from a scattering of infrared and visible light for the early detection of breast cancer. Mathematical sciences professors Taufiquar Khan of Clemson and Peter Maass of the University of Bremen are developing mathematical models to improve resolution.

While the method is less expensive, safer and more comfortable than X-rays used in mammograms, the problem is it not generating a strong enough resolution to detect smaller breast cancers.

DOT may eliminate harmful radiation to the body as well as false positives and negatives caused by mammography X-rays. Researchers hope that the discomfort of mammograms will become a thing of the past and that DOT will enable diagnostic imaging eventually to be done in a home setting. It could also possibly be used as an adjunct to diagnostic procedures such as ultrasound.

For more information: www.clemson.edu


Related Content

News | Breast Imaging

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This ...

Time April 02, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Breast Imaging

March 30, 2026 — Each year, the Alumni Association at the University of Missouri-Kansas City, recognizes the ...

Time March 31, 2026
arrow
News | MRI Breast | Breast cancer, dense breast, MRI

March 2, 2026 — A collaborative modeling study found that adding biennial breast magnetic resonance imaging (MRI) to ...

Time March 20, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
Subscribe Now